control trial cours recombin human interferon-alpha chronic delta type hepat multicent italian studi long-term therapi recombin interferon-alpha cours chronic delta hepat italian patient diseas time week mo mo treatment end studi patient followed-up addit month normal decreas baselin serum alt level treat patient fourth month therapi twelfth month twenty-fourth month control group relaps mo mean mo cessat therapi liver biopsi baselin twelfth month treatment histolog improv decreas portal inflamm treat untreat patient measur antivir activ serum hepat delta viru rna intrahepat hepat delta antigen similar level treat control patient treat patient percentag patient neg hdv rna baselin interferon-alpha dosag studi antivir effect patient chronic hepat hepat inflamm alt level durat reinstitut interferon-alpha therapi long-term control alt level prevent chronic liver damag 